Clover Health Investments Corp (NASDAQ: CLOV) kicked off on Friday, up 0.25% from the previous trading day, before settling in for the closing price of $4.07. Over the past 52 weeks, CLOV has traded in a range of $0.61-$4.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 52.25% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 73.20%. With a float of $376.30 million, this company’s outstanding shares have now reached $394.44 million.
In an organization with 552 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 33.96%, operating margin of -5.84%, and the pretax margin is -6.21%.
Clover Health Investments Corp (CLOV) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Healthcare Plans Industry. The insider ownership of Clover Health Investments Corp is 24.91%, while institutional ownership is 16.40%. The most recent insider transaction that took place on Aug 09 ’24, was worth 999,596. In this transaction Director of this company bought 531,700 shares at a rate of $1.88, taking the stock ownership to the 1,409,267 shares. Before that another transaction happened on Jun 17 ’24, when Company’s Director bought 877,567 for $1.14, making the entire transaction worth $1,000,426. This insider now owns 877,567 shares in total.
Clover Health Investments Corp (CLOV) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 73.20% per share during the next fiscal year.
Clover Health Investments Corp (NASDAQ: CLOV) Trading Performance Indicators
Take a look at Clover Health Investments Corp’s (CLOV) current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.19, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.14 in one year’s time.
Technical Analysis of Clover Health Investments Corp (CLOV)
Let’s dig in a bit further. During the last 5-days, its volume was 7.99 million. That was better than the volume of 6.69 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 94.22%. Additionally, its Average True Range was 0.21.
During the past 100 days, Clover Health Investments Corp’s (CLOV) raw stochastic average was set at 72.06%, which indicates a significant decrease from 95.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.28% in the past 14 days, which was lower than the 75.17% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.40, while its 200-day Moving Average is $2.35. However, in the short run, Clover Health Investments Corp’s stock first resistance to watch stands at $4.14. Second resistance stands at $4.19. The third major resistance level sits at $4.25. If the price goes on to break the first support level at $4.02, it is likely to go to the next support level at $3.96. The third support level lies at $3.90 if the price breaches the second support level.
Clover Health Investments Corp (NASDAQ: CLOV) Key Stats
The company with the Market Capitalisation of 2.04 billion has total of 501,109K Shares Outstanding. Its annual sales at the moment are 2,034 M in contrast with the sum of -213,360 K annual income. Company’s last quarter sales were recorded 330,990 K and last quarter income was -9,160 K.
